PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.79%
Positive growth while CRON.TO shows revenue decline. John Neff would investigate competitive advantages.
-28.77%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
66.19%
Similar gross profit growth to CRON.TO's 80.11%. Walter Schloss would investigate industry dynamics.
64.88%
Similar margin change to CRON.TO's 73.12%. Walter Schloss would investigate industry pricing power.
-72.57%
Both companies reducing R&D. Martin Whitman would check industry innovation trends.
6.30%
G&A growth 50-75% of CRON.TO's 11.21%. Bruce Berkowitz would examine operational efficiency.
16.10%
Marketing expense growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
119.87%
Other expenses growth above 1.5x CRON.TO's 14.25%. Michael Burry would check for concerning trends.
7.55%
Operating expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-16.92%
Both companies reducing total costs. Martin Whitman would check industry trends.
-35.94%
Both companies reducing interest expense. Martin Whitman would check industry trends.
168.49%
D&A growth above 1.5x CRON.TO's 22.08%. Michael Burry would check for excessive investment.
107.32%
EBITDA growth exceeding 1.5x CRON.TO's 7.78%. David Dodd would verify competitive advantages.
-35.86%
EBITDA margin decline while CRON.TO shows 1.96% growth. Joel Greenblatt would examine position.
131.77%
Operating income growth exceeding 1.5x CRON.TO's 25.60%. David Dodd would verify competitive advantages.
131.53%
Operating margin growth while CRON.TO declines. John Neff would investigate advantages.
67.77%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
96.02%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
96.05%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
165.32%
Tax expense growth less than half of CRON.TO's 32859.05%. David Dodd would verify if advantage is sustainable.
94.53%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
94.58%
Net margin growth while CRON.TO declines. John Neff would investigate advantages.
94.63%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
94.63%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
0.77%
Share count reduction below 50% of CRON.TO's 1.37%. Michael Burry would check for concerns.
0.77%
Diluted share change of 0.77% while CRON.TO is stable. Bruce Berkowitz would verify approach.